Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia

被引:0
作者
Serretti, A [1 ]
Cusin, C [1 ]
Lorenzi, C [1 ]
Lattuada, E [1 ]
Lilli, R [1 ]
Smeraldi, E [1 ]
机构
[1] Univ Milan, Ist Sci Osped San Raffaele, Dept Neurospychiat Sci, Sch Med, I-20127 Milan, Italy
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2000年 / 96卷 / 01期
关键词
serotonin; serotonin receptors; schizophrenia; phenotype;
D O I
10.1002/(SICI)1096-8628(20000207)96:1<84::AID-AJMG17>3.0.CO;2-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The serotonin receptor type 2A (5-HT2A) is a primary candidate for involvement in major psychoses. Polymorphisms within the 5-HT2A gene have recently been reported to be associated with a variety of psychopathological conditions. In the present study, we investigated the potential influence of the T102C polymorphism on the psychopathology of schizophrenia. One hundred eighty-eight inpatients affected by schizophrenia (DSM-III-R) were assessed by the Operational Criteria checklist for psychotic illness (OPCRIT) and were typed for their 5-HT2A variants by PCR techniques. Mania, depression, delusion and disorganization were the four symptomatologic factors previously derived from our psychotic population that were used to define phenotype in our sample. Genetic variants of the polymorphism under study were not associated with these symptomatologic factors, and consideration of possible stratification effects such as sex and age of onset did not reveal any association either. Our results do not, therefore, support the hypothesis that the serotonin receptor 2A gene is a liability factor for the symptomatology of schizophrenia as defined by the OPCRIT checklist, Am. J. Med. Genet. (Neuropsychiatr. Genet;.) 96:84-87, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:84 / 87
页数:4
相关论文
共 59 条
[1]   SEROTONIN2 RECEPTOR-BINDING IN BLOOD-PLATELETS OF SCHIZOPHRENIC-PATIENTS [J].
ARORA, RC ;
MELTZER, HY .
PSYCHIATRY RESEARCH, 1993, 47 (02) :111-119
[2]   ASSOCIATION BETWEEN CLOZAPINE RESPONSE AND ALLELIC VARIATION IN 5HT(2A) RECEPTOR GENE [J].
ARRANZ, M ;
COLLIER, D ;
SODHI, M ;
BALL, D ;
ROBERTS, G ;
PRICE, J ;
SHAM, P ;
KERWIN, R .
LANCET, 1995, 346 (8970) :281-282
[3]  
Arranz MJ, 1996, LANCET, V347, P1831
[4]  
BARBUJANI G, 1991, HUM BIOL, V63, P253
[5]   SEROTONERGIC MECHANISMS IN PSYCHIATRIC-DISORDERS - NEW RESEARCH TOOLS, NEW IDEAS [J].
BENKELFAT, C .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 8 :53-56
[6]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[7]  
Bradley CC, 1997, J NEUROCHEM, V69, P1356
[8]   SEROTONIN, SCHIZOPHRENIA AND ANTIPSYCHOTIC DRUG-ACTION [J].
BREIER, A .
SCHIZOPHRENIA RESEARCH, 1995, 14 (03) :187-202
[9]   THE DISTRIBUTION OF 5-HT1A AND 5-HT2A RECEPTOR MESSENGER-RNA IN HUMAN BRAIN [J].
BURNET, PWJ ;
EASTWOOD, SL ;
LACEY, K ;
HARRISON, PJ .
BRAIN RESEARCH, 1995, 676 (01) :157-168
[10]   Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia [J].
Busatto, GF ;
Kerwin, RW .
JOURNAL OF PSYCHOPHARMACOLOGY, 1997, 11 (01) :3-12